Genmab — December 2019

[JKY_VH]

lyder godt bibob og rigtig glædelig jul:-)

[JKY_VH]

her er linket i øvrigt https://play.borsen.dk/klip/5dfae237595ab4f00a338012

[Sukkeralf]

If approved, belantamab mafodotin would likely slot in before Xpovio (selinexor) but unlikely to challenge Darzalex (daratumumab)

[Sukkeralf]

“I don’t think that’s going to happen. Physicians are so familiar with Darzalex, especially community oncologists who treat every oncologic disorder under the sun, and they are also slow to adopt new drugs. Specialists focused on myeloma will pick belantamab mafodotin up quicker but rest of community will be slower. Response rates with Darzalex-based combinations, and even complete response rates, are superior.”

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[Sukkeralf]

Glædelig jul til alle

[Helge_LarsenPI-redaktør]

I lige måde Sukker.

[bibob]

JKY 10.25. Ilm.

[Teller]

Glædelig jul allesammen... Har vi forøvrigt fået Recept tal for November endnu?

[henrik48]

Glædelig jul til alle fra det midtjyske

[MarsFars]

Merry juuul

[nohope]

Okay, okay, hvis det ikke kan være anderledes så - Glædelig Jul

[kkjoel]

Og så kom der en lille - og lidt forsinket - julegave alligevel: AQR Capital Management reducerer deres shortposition fra 0,79 til 0.69 %. De tør sgu ikke længere.. tænke sig hvad den kunne stryge op i når foråret - og måske en større nyhed - endelig kommer. Genmab lukker i 22,58 ~ 1524. Glædelig jul!

[kkjoel]

https://oasm.finanstilsynet.dk/dk/soegmeddelelseresultat.aspx?headline=&name=genmab&RealAnnouncerCVR=&CVRnumber=&announcmentsId=&informationTypeId=23&languageId=-1&nationality=-1&AnnouncementTypeId=&historic=1&pubDateFrom=2019-09-25 00:00&pubDateTo=2019-12-25 01:14&index=1&sindex=1

[bikube]

Ja - tænk lige, hvad AQR kunne have sparet, hvis de havde lukket de shorts i kurs 800 i efteråret -18

[peter12]

Mon ikke det har kostet hoveder ? https://www.bloomberg.com/news/articles/2019-04-05/aqr-head-of-machine-learning-set-to-leave-after-less-than-a-year

[Darvin]

En rigtig god julehistorie (17.12) fra en (Don) vi G- mappere har fulgt i flere år. “Not Dead Yet

Not even close, doing pretty well actually” MM siden 2003 og skriver mere: “I've been on Pomalyst (Pom) since March of 2008, with the exception of one year when the Pom trial ended. Trials of three different experimental regimens failed me then, but Darzalex became approved and the combo of Darzalex, Pom, and dexamethasone (dex) brought my numbers way back down“

[Darvin]

Myeloma Hope

Minnesota Don discusses treatments for multiple myeloma and his own experiences with them.

(myelomahope.blogspot.com)

[JKY_VH]

Tak for den Darvin og glædelig bagjul:-)

[E_L]

innovaTV 207 adds a second arm, looks like a more precise dosing schedule. Adds 50 patients to 250. https://clinicaltrials.gov/ct2/history/NCT03485209?A=25&B=26&C=merged#StudyPageTop